{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:48:54Z","timestamp":1791582534832,"version":"4.3.4"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"The foundation for the promotion of Norwegian pharmacies","award":["2023.08"],"award-info":[{"award-number":["2023.08"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The study investigated the knowledge and awareness of anti-doping regulations among community pharmacists in Norway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The research employed a simulated patient methodology, involving 296 pharmacists, to assess their ability to identify prohibited substances and provide appropriate anti-doping advice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>The findings reveal that 46.6% of pharmacists could identify salbutamol as a prohibited substance, with only 23.3% providing comprehensive anti-doping guidance. The study highlights a significant knowledge gap, emphasizing the need for enhanced educational programs to equip pharmacists with the necessary skills to offer effective anti-doping advice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results underscore the critical role of community pharmacists in promoting a vigilant healthcare environment against doping in sports.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijpp\/riaf128","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:53:35Z","timestamp":1765976015000},"page":"140-146","source":"Crossref","is-referenced-by-count":2,"title":["Anti-doping awareness among community pharmacists in Norway: a study using a simulated patient"],"prefix":"10.1093","volume":"34","author":[{"given":"Sofie","family":"Christensen","sequence":"first","affiliation":[{"name":"Department of Science and Medicine, Anti-Doping Norway , 0855 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9162-9554","authenticated-orcid":false,"given":"Ingunn","family":"Bj\u00f6rnsdottir","sequence":"additional","affiliation":[{"name":"Section of Pharmaceutics and Social Pharmacy, Department of Pharmacy, University of Oslo , 0316 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Lauritzen","sequence":"additional","affiliation":[{"name":"Department of Science and Medicine, Anti-Doping Norway , 0855 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4444-1794","authenticated-orcid":false,"given":"Astrid","family":"Gjelstad","sequence":"additional","affiliation":[{"name":"Department of Science and Medicine, Anti-Doping Norway , 0855 Oslo ,","place":["Norway"]},{"name":"Section of Pharmaceutical Chemistry, Department of Pharmacy, University of Oslo , 0316 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"2026040801444941700_ref1","volume-title":"World Anti-Doping Code","year":"2021"},{"key":"2026040801444941700_ref2","volume-title":"International Standard Prohibited List 2025","year":"2025"},{"key":"2026040801444941700_ref3","volume-title":"International Standard Therapeutic Use Exemptions 2023","year":"2023"},{"key":"2026040801444941700_ref5","volume-title":"Sports Pharmacy Pratice and Education: A Global Overview","year":"2022"},{"key":"2026040801444941700_ref6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5688\/ajpe798119","article-title":"Knowledge and perceptions of pharmacy students in Qatar on anti-doping in sports and on sports pharmacy in undergraduate curricula","volume":"79","author":"Awaisu","year":"2015","journal-title":"Am J Pharm Educ"},{"key":"2026040801444941700_ref7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s13104-017-2713-7","article-title":"Knowledge of pharmacy students about doping, and the need for doping education: a questionnaire survey","volume":"10","author":"Shibata","year":"2017","journal-title":"BMC Res Notes"},{"key":"2026040801444941700_ref8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/pharmacy12010003","article-title":"Competence in sports pharmacy among pharmacy students in Norway","volume":"12","author":"Dabrowska","year":"2023","journal-title":"Pharmacy (Basel)"},{"key":"2026040801444941700_ref9","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1186\/s12909-023-04795-z","article-title":"Assessing anti-doping knowledge among Taiwanese pharmacists","volume":"23","author":"Lee","year":"2023","journal-title":"BMC Med Educ"},{"key":"2026040801444941700_ref10","doi-asserted-by":"publisher","first-page":"100195","DOI":"10.1016\/j.peh.2021.100195","article-title":"Anti-doping knowledge and educational needs of Finnish pharmacists","volume":"9","author":"Lemettil\u00e4","year":"2021","journal-title":"Perform Enhance Health"},{"key":"2026040801444941700_ref11","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy8010010","article-title":"Pharmacists as a source of advice on medication use for athletes","volume":"8","author":"Yee","year":"2020","journal-title":"Pharmacy (Basel)"},{"key":"2026040801444941700_ref12","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.japh.2018.05.003","article-title":"Perspectives of athletes and pharmacists on pharmacist-provided sports supplement counseling: an exploratory study","volume":"58","author":"Howard","year":"2018","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2026040801444941700_ref13","doi-asserted-by":"publisher","first-page":"e0268878","DOI":"10.1371\/journal.pone.0268878","article-title":"Engaging community pharmacists to eliminate inadvertent doping in sports: a study of their knowledge on doping","volume":"17","author":"Voravuth","year":"2022","journal-title":"PLoS One"},{"key":"2026040801444941700_ref14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/jphs.12346","article-title":"Beyond medicines provision: community pharmacists roles in meeting patient needs through value-added pharmacy services","volume":"11","author":"Chukwu","year":"2020","journal-title":"J Pharm Health Serv Res"},{"key":"2026040801444941700_ref15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.51847\/TIT76VnUlP","article-title":"Knowledge, attitude, and behaviour regarding doping in sports among physicians and pharmacists: a questionnaire-based study","volume":"11","author":"Salih","year":"2021","journal-title":"J Adv Pharm Educ Res"},{"key":"2026040801444941700_ref16","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/ijpp\/riad015","article-title":"Examining pharmacists\u2019 anti-doping knowledge and skills in assisting athletes to avoid unintentional use of prohibited substances","volume":"31","author":"Greenbaum","year":"2023","journal-title":"Int J Pharm Pract"},{"key":"2026040801444941700_ref17","volume-title":"Anti-Doping Awareness among Community Pharmacists in Norway: A Study Using a Simulated Patient","author":"Christensen","year":"2025"},{"key":"2026040801444941700_ref18","author":"Regional Committees for Medical and Health Research Ethics","year":"2025"},{"key":"2026040801444941700_ref19","volume-title":"Guidelines for Research Ethics in the Social Sciences and the Humanities","year":"2022"},{"key":"2026040801444941700_ref20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/ijpp\/riae019","article-title":"Refining the CRiSPHe (checklist for reporting research using a simulated patient methodology in health): a Delphi study","volume":"32","author":"Park","year":"2024","journal-title":"Int J Pharm Pract"},{"key":"2026040801444941700_ref21","volume-title":"FIP GUIDELINES. The Role of the Pharmacist in the Fight against Doping in Sport","year":"2014"},{"key":"2026040801444941700_ref22","year":"2024"},{"key":"2026040801444941700_ref23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1211\/ijpp.14.2.0002","article-title":"A systematic review of the use of simulated patients and pharmacy practice research","volume":"14","author":"Watson","year":"2010","journal-title":"Int J Pharm Pract"},{"key":"2026040801444941700_ref24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.sapharm.2008.08.006","article-title":"A review of counseling practices on prescription medicines in community pharmacies","volume":"5","author":"Puspitasari","year":"2009","journal-title":"Res Social Adm Pharm"},{"key":"2026040801444941700_ref25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/pharmacy11020047","article-title":"Using the simulated patient methodology in the form of mystery calls in community pharmacy practice research: a scoping review protocol","volume":"11","author":"Kunow","year":"2023","journal-title":"Pharmacy"},{"key":"2026040801444941700_ref26","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.pec.2018.05.018","article-title":"Evaluation of a structured pharmacist-led inhalation technique assessment service for patients with asthma and COPD in Norwegian pharmacies","volume":"101","author":"Ruud","year":"2018","journal-title":"Patient Educ Couns"},{"key":"2026040801444941700_ref27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/ejhpharm-2012-000253","article-title":"Development and delivery of pharmacy services for the London 2012 Olympic and Paralympic games","volume":"20","author":"Stuart","year":"2013","journal-title":"Eur J Hosp Pharm"},{"key":"2026040801444941700_ref28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/pharmacy7010029","article-title":"Current and potential roles in sports pharmacy: a systematic review","volume":"7","author":"Hooper","year":"2019","journal-title":"Pharmacy (Basel)."}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/34\/2\/140\/66322815\/riaf128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/34\/2\/140\/66322815\/riaf128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:44:52Z","timestamp":1775627092000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/34\/2\/140\/8418000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1,9]]},"published-print":{"date-parts":[[2026,4,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ijpp\/riaf128","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,1,9]]}}}